| Sandoz Pharmaceuticals AG - Paliperidon Sandoz 150 mg/1.5 ml, Depot-Injektionssuspension in einer Fertigspritze | | 69749 | | 05 | | Paliperidon Sandoz 150 mg/1.5 ml | | Depot-Injektionssuspension in einer Fertigspritze | | N05AX13 | | Paliperidone | | 18.07.2025 | | |
| | Composition | | paliperidonum 150 mg ut paliperidoni palmitas, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 1.5 ml corresp. natrium 4.18 mg. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | | PR | PR | B | | Yes |
|
|
